BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 2014
View Archived Issues
Korean group prepares new monoclonal antibodies
Read More
Cedars-Sinai begins phase I trial of brain cancer vaccine
Read More
Venaxis completes enrollment in pivotal U.S. trial of APPY1 Test for appendicitis
Read More
GERD linked to FOXF1 and MHC locus gene polymorphisms
Read More
Researchers at Esteve design novel sigma1 receptor ligands
Read More
Tekmira commences phase I trial of TKM-100802
Read More
New casein kinase 2 inhibitors disclosed by Bristol-Myers Squibb
Read More
Genentech and Roche disclose new ROR-gamma modulators
Read More
PARSiFAL trial to investigate BAY-1067197 in heart failure
Read More
Mallinckrodt begins patient recruitment in phase I trial of MP-3549.1 in advanced solid tumors
Read More
Patient recruitment begins in phase I trial of Ribological's personalized anticancer vaccine
Read More
Transgene prepares novel tuberculosis vaccines
Read More
DioGenix discloses new data supporting efficacy of multiple sclerosis assay
Read More
Maruho to take over marketing rights for Protopic ointment in Japan
Read More
Data presented from AIMSPRO study in diffuse systemic sclerosis
Read More
OncoCyte commences clinical development of bladder cancer diagnostics in U.S. and China
Read More
Alcobra reports promising results from new study of MG-01CI in animal model of fragile X syndrome
Read More
Phase I study of A*STAR and Cytos' H1N1 influenza vaccine meets primary immunogenicity endpoint
Read More
FDA committee recommends approval of Ragwitek BLA
Read More
Amgen's LAPLACE-2 phase III trial of evolocumab in combination with statins meets primary endpoints
Read More
Oncolys BioPharma commences phase I/II trial of Telomelysin in Korea and Taiwan
Read More
Sosei offers development update on glycopyrronium bromide programs
Read More
VCN Biosciences to advance VCN-01 oncolytic adenovirus to clinic
Read More
PARP-1 inhibitors developed at Lupin
Read More
Astellas reports melatonin agonists for urinary incontinence
Read More